Open labelled, Randomized control trial comparing upfront Rituximab and Mycophenolate Mofetil use with Mycophenolate mofetil alone in patients with Systemic sclerosis related interstitial lung disease

Authors
Category Primary study
Registry of TrialsClinical Trials Registry - India
Year 2025
This article has no abstract
Epistemonikos ID: 8fb8ad0a93f1abdbcd859cbaf5f2af718c179e95
First added on: Apr 24, 2026